Drug Testing Equipment Market Analysis

  • Report ID: 3821
  • Published Date: Nov 20, 2025
  • Report Format: PDF, PPT

Drug Testing Equipment Market Segmentation:

Sample (Blood, Urine, Oral Fluids, Breath, Hair)

The urine segment in the drug testing equipment market is expected to garner the largest revenue share of 35% by the year 2035 due to the growing use and trade of illegal and banned drugs such as opioids. Urine drug tests are majorly used to detect the positivity of substance abuse which is a cost-effective and non-invasive method that aids in the rapid detection of drug intake.

Moreover, the hair segment is further foreseen to witness to bring in notable revenue owing to its rapid adoption as is the least invasive method and this testing provides an extended detection window of about 90 days.

End User (Personal Users, Hospitals, Workplace & Schools, Criminal Justice Systems and Law Enforcement Agencies, Drug Testing Laboratories, Drug Treatment Centers, and Pain Management Centers)

Drug testing equipment market from the workplace & school segment will hold a significant growth rate in the upcoming years. With the changing organizational policies and the growing percentage of jobs requiring background verification for accessing workplace employment eligibility, the adoption of pre-employment drug tests is increasing. This will lead the segment to rise.

Our in-depth analysis of the global market includes the following segments:

            Product

  • Consumables
  • Urine Testing Kits
  • Rapid Test Devices
  • Breathalyzer
  • Chromatography

           Sample

  • Blood
  • Urine
  • Oral Fluids
  • Breath
  • Hair

           End User

  • Personal Users
  • Hospitals
  • Workplace & Schools
  • Criminal Justice Systems and Law Enforcement Agencies
  • Drug Testing Laboratories
  • Drug Treatment Centers
  • Pain Management Centers

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of drug testing equipment is evaluated at USD 9.71 billion.

The global drug testing equipment market size was worth over USD 8.82 billion in 2025 and is poised to grow at a CAGR of around 11.2%, reaching USD 25.5 billion revenue by 2035.

The North America drug testing equipment market is forecast to secure nearly 40% share by 2035, reinforced by the strong presence of industry players promoting drug screening and the heightened concern over escalating drug abuse in the region.

Key players in the market include Sandoz International GmbH, Quest Diagnostics Incorporated, Butterfly Network, Inc., F. Hoffmann-La Roche, Thermo Fisher Scientific, Inc., Siemens AG, Bio-Rad Laboratories, Inc., Cordant Health Solutions, Legacy Medical Services, LLC, Omega Laboratories, Inc., GE Healthcare.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos